News

Welcome to the CLINUVEL News page. Discover the latest in clinical, corporate, and regulatory updates.

Change in Director’s Interest Notice

2018 Announcements

06.07.2018

Change in substantial holding

2018 Announcements

04.07.2018

CLINUVEL COMPLETES SCENESSE® FDA FILING

2018 Announcements

25.06.2018

Trading Halt

2018 Announcements

22.06.2018

Appendix 3B

2018 Announcements

01.06.2018

NICE MAINTAINS ITS POSITION NOT TO RECOMMEND SCENESSE® FOR REIMBURSEMENT

2018 Announcements

23.05.2018

Change in substantial holding

2018 Announcements

17.05.2018

Change in substantial holding

2018 Announcements

16.05.2018

CLINUVEL REGULATORY UPDATE

2018 Announcements

14.05.2018

Change in substantial holding

2018 Announcements

01.05.2018

CLINUVEL TO TAKE 100% OWNERSHIP OF VALLAURIX

2018 Announcements

01.05.2018

Appendix 4C

2018 Announcements

30.04.2018

CLINUVEL Newsletter – March 2018

2018 Announcements

26.03.2018

.

Go To Top